BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Illumina, Inc. Expands GoldenGate(R) Genotyping Portfolio With Launch Of Three Content Products And Reduced-Complexity Array Matrix

  March 7, 2006

   · 

  1 min read
• Policy

  IMPAX Laboratories, Inc. Receives FDA Non-Approvable Letter For Vadova; Company To Request Meeting With FDA

  March 7, 2006

   · 

  1 min read
• Pharm Country

  Genta Incorporated Announces Common Stock Offering Of Approximately $40.8 Million

  March 7, 2006

   · 

  2 min read
• Policy

  FDA Grants Priority Review For Bristol-Myers Squibb Company’s Investigational Oncology Treatment Dasatinib

  March 7, 2006

   · 

  1 min read
• Drug Development

  Baxter Healthcare Corporation Commences First-Of-Its-Kind, Phase II Adult Stem Cell Trial In U.S. in Patients With Severe Coronary Artery Disease

  March 7, 2006

   · 

  5 min read
• Business

  Neoprobe Corporation Announces 2005 Annual Results

  March 7, 2006

   · 

  1 min read
• Business

  Myogen Reports 2005 Results

  March 7, 2006

   · 

  1 min read
• Drug Development

  Aradigm Corporation Reports Novo Nordisk A/S To Initiate Additional Phase 3 Clinical Trials Of AERx Diabetes Management System

  March 7, 2006

   · 

  1 min read
• Drug Development

  BioMS Medical’s MBP8298 Shows Five-Year Delay Of Disease Progression In Patients With Multiple Sclerosis

  March 7, 2006

   · 

  1 min read
• Business

  Mologen AG’s Technological Advancements Enhance License Business Potential Strategic Focus Concentrated Through Termination Of Arab Joint Venture

  March 7, 2006

   · 

  1 min read